Abstract:50 Background: Extrahepatic cholangiocarcinoma (ECC) and intrahepatic cholangiocarcinoma (ICC) are two types of malignant tumors that arise from the bile duct epithelium at different locations. Currently, effective treatment options for these tumors are limited, and their microenvironmental differences remain poorly understood. Methods: We collected retrospective clinicopathological data of ECC (N=64) and ICC (N=153) patients from our hospital and integrated public database information to analyze the clinical characteristics, survival, and prognosis of ECC and ICC. We performed single-cell sequencing (scRNA-seq) and spatial transcriptomic techniques on three ECC and three ICC tumor tissues. Verification of scRNA-seq results was done using immunohistochemistry, flow cytometry, and polychromatic immunofluorescence. Additionally, we analyzed RNA and ATAC sequencing data for exhausted CD8+ T cells TEX obtained from ICC and ECC tissue samples. We used InferCNV to infer copy number variations (CNVs) of epithelial cells from ICC and ECC. Results: Our results showed that ECC and ICC differ in their clinical characteristics such as age, gender, bilirubin, CEA, and outcome. ECC had higher copy number amplification variation and exhibited inflammatory signaling and ongoing immunoediting, reflected in higher immune checkpoint expression such as PDCD1, CTLA4, and LAG3, and tumor infiltration with highly differentiated dysfunctional PDCD1+ LAG3+ CXCL13+ exhausted CD8+ T cells (TEX) and precursors of exhausted T (TPEX). RNA velocity analysis revealed different developmental trajectories of T cells in ECC and ICC, predominantly in naive/stem-like and memory T cells. We also identified a trefoil factor 3 (TFF3)-positive epithelial subpopulation in ECC. TFF3+ epithelial cells had closer interaction with CTHRC1+ fibroblasts, which induced more CD8+ T cells to TEX and TPEX. TFF3+ cells exhibited higher CNV scores and higher PD-L1 and PD-L2 expression, and co-localized with TEX and TPEX, providing one explanation for the immunosuppressive environment in ECC and suggesting a potential response to immune checkpoint therapy (ICT). Conclusions: Our study provides a comprehensive characterization of the cellular heterogeneity landscape of ECC and ICC, which can guide the optimization of personalized cancer immunotherapy. We identified potential biomarkers and targets for immunotherapies, and our findings shed light on the underlying mechanisms of tumor immune evasion and provide a foundation for further research in this area.

Differentially Expressed Gene Profiles of Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma, and Combined Hepatocellular-Cholangiocarcinoma by Integrated Microarray Analysis

Integrative Analysis of Cerna Network Reveals Functional Lncrnas in Intrahepatic Cholangiocarcinoma

Identification of Biomarkers of Intrahepatic Cholangiocarcinoma Via Integrated Analysis of Mrna and Mirna Microarray Data.

Identification of Key Candidate Genes and Pathways in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.

Five Hub Genes Can Be the Potential DNA Methylation Biomarkers for Cholangiocarcinoma Using Bioinformatics Analysis

Screening and identification of key genes between liver hepatocellular carcinoma (LIHC) and cholangiocarcinoma (CHOL) by bioinformatic analysis

Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma

Gene Expression Patterns Combined with Bioinformatics Analysis Identify Genes Associated with Cholangiocarcinoma

Transcriptomic Profiling Reveals Hepatic Stem-Like Gene Signatures and Interplay of Mir-200C and Epithelial-Mesenchymal Transition in Intrahepatic Cholangiocarcinoma.

Retraction Note To: Comparison of Hepatocellular Carcinoma (HCC), Cholangiocarcinoma (CC), and Combined HCC-CC (CHC) with Each Other Based on Microarray Dataset

Identification of Hepatocellular Carcinoma-associated Hub Genes and Pathways by Integrated Microarray Analysis

Integration Analysis of Mirna–mrna Expression Exploring Their Potential Roles in Intrahepatic Cholangiocarcinoma

Coding-noncoding Gene Expression in Intrahepatic Cholangiocarcinoma.

Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated with Clinical Outcome in Hepatocellular Carcinoma

A2M is a potential core gene in intrahepatic cholangiocarcinoma

Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinoma

The expression profiles of circular RNAs and competing endogenous RNA networks in intrahepatic cholangiocarcinoma

Identification of Crucial Genes Based on Expression Profiles of Hepatocellular Carcinomas by Bioinformatics Analysis.

Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.

Screening potential biomarkers of cholangiocarcinoma based on gene chip meta-analysis and small-sample experimental research

Unraveling the Heterogeneity of Intercellular Crosstalk in Intrahepatic and Extrahepatic Cholangiocarcinoma Using Single-Cell and Spatial Transcriptome Profiling.